LabGenius announces research collaboration with Ablynx
LabGenius has announced a research collaboration with Ablynx, a Sanofi company, for therapeutic proteins. Read More
GSK to establish new life science campus in U.K.
GlaxoSmithKline (GSK) has announced plans to develop a more than 1 million-sq-ft life science campus research and development campus in Stevenage, England. Read More
Grit Bio secures funding for development of TIL therapies
Grit Bio has secured a round of financing that it plans to use to develop tumor-infiltrating lymphocyte (TIL) therapies. The funding amount was not disclosed. Read More
Wugen nabs $172M to advance memory NK cell platform
Wugen announced it has raised $172 million to support further development of its NK cell platform and to continue ongoing trials for patients with severe acute myelogenous leukemia. Read More
Shape to advance RNA tech platform with $112M in new funding
Shape Therapeutics announced it raised $112 million in financing to continue building its growing portfolio of RNA technologies. Read More
NIST gives $135M to NIIMBL to bolster U.S. supply chains
The U.S. National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced it has received $153 million in new funding from the National Institute of Standards and Technology (NIST). Read More
AMRA touts clinical trial results
Swedish image analysis software developer AMRA Medical has announced that its whole-body MRI image analysis software performed well in a recent clinical trial. Read More
Sana to open new CGT manufacturing facility
Sana Biotechnology has signed a lease to develop a 163,000-sq-ft manufacturing facility in Fremont, CA, to support the manufacture of its late-stage clinical development and early commercial cell and gene therapy (CGT) candidates. Read More
Forge Biologics to develop, manufacture GentiBio therapies
GentiBio and Forge Biologics have formed a strategic development and manufacturing partnership to advance GentiBio's immune tolerance platform. Read More
Lexogen offers SARS-CoV-2 workflows for variant tracing
Lexogen has validated two workflows that aim to improve SARS-CoV-2 sequencing for tracing variants of the virus. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
